Citadel Advisors
OCRX

Citadel Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Citadel Advisors’s Portfolio OCRX Stock Details OCRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
2017
Q1 		$73K Buy
2016
Q1 		– Sell
2015
Q4 		$59K Buy
2015
Q3 		– Sell
2015
Q2 		$38K Buy
2014
Q2 		– Sell
2014
Q1 		$150K Buy
2013
Q3 		– Sell
2013
Q2 		$12K Buy